L. H. Butler

发表

CD164 Monoclonal Antibodies That Block Hemopoietic Progenitor Cell Adhesion and Proliferation Interact with the First Mucin Domain of the CD164 Receptor1

A. Zannettino, J. Lévesque, P. Simmons, 2000, The Journal of Immunology.

CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21.

A. Zannettino, D. Sheer, P. Simmons, 1998, Blood.

Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues.

A. Zannettino, J. Lévesque, D. Buck, 2000, Blood.

Domain of the CD 164 Receptor Proliferation Interact with the First Mucin Hemopoietic Progenitor Cell Adhesion and CD 164 Monoclonal Antibodies That Block

Rappold, A. Zannettino, J. Lévesque, 2000 .

A randomised, double-blind, placebo-controlled, crossover study to assess the efficacy and safety of three dosing schedules of agalsidase alfa enzyme replacement therapy for Fabry disease.

A. Mehta, D. Hughes, P. Deegan, 2013, Molecular genetics and metabolism.

The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures.

M. Cleary, D. Mason, R. Slany, 1997, Blood.

Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation.

K. Pulford, D. Mason, G. Delsol, 1998, Cancer research.

Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.

K. Pulford, D. Mason, G. Delsol, 1997, Blood.

and Localizes to Nuclear Structures The HRX Proto-oncogene Product Is Widely Expressed in Human Tissues

M. Cleary, D. Mason, R. Slany, 2013 .

Abstract CT248: AZD7648: A Phase I/IIa first-in-human trial of a novel, potent and selective DNA-PK inhibitor in patients with advanced malignancies

T. Yap, D. Landers, E. Cadogan, 2020, Tumor Biology.